Ocugen, Inc(NASDAQ:OCGN) 
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherit...
Website: http://www.ocugen.com
Founded: 2013
Full Time Employees: 16
CEO / Co-Founder: Shankar Musunuri
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.61
H 0.69
L 0.60
C 0.66
V 3,805,310
10EMA 0.66
20EMA 0.66
60EMA 0.66
120EMA 0.66
250EMA 0.66